|
Sign In to gain access to subscriptions and/or personal tools.
|
Albumin Therapy in Clinical Practice
Christian M. Mendez, MD
Craig J. McClain, MD
Luis S. Marsano, MD
Department of Internal Medicine, University of Louisville Medical Center,
Louisville, Kentucky
Correspondence: Correspondence: Christian M. Mendez, M.D., Department of Internal Medicine,
University of Louisville Medical Center, 550 S. Jackson St., ACB 3rd Floor,
Louisville, KY 40292. Electronic mail may be sent to
cmmend01{at}gwise.louisville.edu.
Albumin is the predominant product of hepatic protein synthesis and one of
the more abundant plasma proteins. Among its multiple physiologic roles, it
plays an essential part in the generation of colloid-oncotic pressure. In the
United States, the indications for which albumin therapy are considered
include hypovolemia or shock, burns, hypoalbuminemia, surgery or trauma,
cardiopulmonary bypass, acute respiratory distress syndrome, hemodialysis, and
sequestration of protein-rich fluids. The use of this relatively expensive
therapy accounts for up to 30% of the total pharmacy budget in certain
hospitals. The use of albumin therapy in different clinical situations and its
influence in morbidity and mortality have been reviewed in multiple randomized
controlled trials and meta-analyses. Despite frequent reviews, the use of
albumin remains controversial in several clinical situations. At the same
time, these valuable reviews seem to have documented the advantages of albumin
therapy in the management of ascites and clarified the use of albumin in
volume resuscitation. More studies have been recommended to investigate the
use of albumin in different doses and its role in hypoalbuminemia. This
article will provide an overview of albumin metabolism, use of albumin for
volume expansion, the potential therapeutic role of albumin in liver disease,
and the role of albumin therapy in nutrition.
Nutrition in Clinical Practice, Vol. 20, No. 3,
314-320 (2005)
DOI: 10.1177/0115426505020003314

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. T. Mosby, R. D. Barr, and P. B. Pencharz
Nutritional Assessment of Children With Cancer
Journal of Pediatric Oncology Nursing,
July 1, 2009;
26(4):
186 - 197.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Reynolds and M. McKee
Matching supply and demand for blood in Guizhou province, China: an unresolved challenge
J. Public Health Med.,
April 20, 2009;
(2009)
fdp030v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. L. George, M. Gertsenstein, K. Vintersten, E. Korets-Smith, J. Murphy, M. E. Stevens, J. J. Haigh, and A. Nagy
Developmental and adult phenotyping directly from mutant embryonic stem cells
PNAS,
March 13, 2007;
104(11):
4455 - 4460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Boldt, T. Scholhorn, J. Mayer, S. Piper, and S. Suttner
The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery.
Anesth. Analg.,
July 1, 2006;
103(1):
191 - 199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. O. Lipman
When is a Controversy Not a Controversy? Escaping Never-Never Land
Nutr Clin Pract,
June 1, 2005;
20(3):
291 - 293.
[Full Text]
[PDF]
|
 |
|
|
|